Diana Campelo Delgado,  —

Articles by

Soleo Health to Administer Givlaari to Adults With AHP

Soleo Health announced it will start to administer Givlaari (givosiran), an injectable treatment by Alnylam Pharmaceuticals’ for adults with acute hepatic porphyria (AHP). “We are once again expanding our portfolio of infusible and injectable specialty pharmaceuticals to elevate our levels of quality patient care and therapeutic service offerings.